Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Wascher, TC; Paulweber, B; Toplak, H; Saely, CH; Drexel, H; Föger, B; Hoppichler, F; Stulnig, T; Stingl, H; Clodi, M; den Ausschuss Leitlinien.
[Lipids-Diagnosis and therapy in diabetes mellitus (Update 2019)].
Wien Klin Wochenschr. 2019; 131(Suppl 1):136-138
Doi: 10.1007/s00508-019-1444-2
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Toplak Hermann
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Hyper- and dyslipidemia contribute to cardiovascular morbidity and mortality in diabetic patients. Pharmacological therapy to lower LDL cholesterol has convincingly shown to reduce cardiovascular risk in diabetic patients. The present article represents the recommendations of the Austrian Diabetes Association for the use of lipid-lowering drugs in diabetic patients according to current scientific evidence.
- Find related publications in this database (using NLM MeSH Indexing)
- -
- Cardiovascular Diseases - drug therapy
- Cardiovascular Diseases - epidemiology
- Comorbidity -
- Diabetes Complications - drug therapy
- Dyslipidemias - drug therapy
- Dyslipidemias - epidemiology
- Humans -
- Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
- Hypolipidemic Agents - therapeutic use
- Lipids -
- Practice Guidelines as Topic -
- Risk Factors -
- Find related publications in this database (Keywords)
- Hyperlipidemia
- Statins
- Diabetes mellitus